Congenital endplate acetylcholinesterase deficiency responsive to ephedrine

M. Bestué-Cardiel, A. Sáenz de Cabezón-Alvarez, J.L. Capablo-Liesa, Javier López Pisón, José Luis Peña Segura, J. Martín-Martínez, Andrew G. Engel

Neurology · 2005 · 77 citations · 9 references

Concepts

Abstract

The authors describe two patients with congenital myasthenic syndrome (CMS) with end plate acetylcholinesterase (AChE) deficiency caused by mutations in the collagenic tail (ColQ) of AChE: a homozygous C-terminal Y230S mutation in Patient 1 and Y430S and a C-terminal splice-site mutation in Patient 2. In Patient 1, a Prostigmin (neostigmine bromide) test failed to distinguish between AChE deficiency and a slow-channel CMS. Both patients responded dramatically to ephedrine therapy.

References

9